Tadalafil 10mg Daily is NOT Better Than 5mg Daily for BPH
For benign prostatic hyperplasia, use tadalafil 5mg once daily—this is the only FDA-approved dose and the only dose recommended by clinical guidelines for BPH treatment. There is no evidence supporting 10mg daily dosing for BPH, and using this dose would be off-label without demonstrated benefit.
FDA-Approved Dosing is Clear
The FDA label explicitly states that the recommended dose of tadalafil for once daily use in BPH is 5mg, taken at approximately the same time every day 111. This applies whether treating BPH alone or BPH with concurrent erectile dysfunction. The 10mg dose is only approved for "as-needed" use in erectile dysfunction, not for daily BPH management.
Guideline Recommendations Support 5mg Daily Only
The 2021 AUA Guidelines provide a Moderate Recommendation (Evidence Level: Grade B) that 5mg daily tadalafil should be discussed as a treatment option for patients with LUTS/BPH, regardless of whether they have comorbid erectile dysfunction 22. The guidelines analyzed ten key trials comparing tadalafil 5mg to placebo (n=5,129 patients) and found meaningful improvements in IPSS scores and treatment response rates. Notably, the guidelines make no mention of 10mg daily dosing for BPH—because it hasn't been studied or approved for this indication.
Clinical Trial Evidence Demonstrates 5mg Efficacy
The dose-finding study by Roehrborn et al. (2008) evaluated multiple daily doses (2.5,10, and 20mg) for BPH-LUTS 3. While all doses showed statistically significant improvements over placebo, the study concluded that 5mg tadalafil "appeared to provide a positive risk-benefit profile" for once-daily use. The improvements in IPSS scores were:
- Placebo: -2.3 points
- 2.5mg: -3.9 points (p=0.015)
- 5mg: -4.9 points (p<0.001)
- 10mg: -5.2 points (p<0.001)
- 20mg: -5.2 points (p<0.001)
The marginal additional benefit of 10mg over 5mg (0.3 IPSS points) is clinically insignificant and does not justify the higher dose, especially considering potential increased adverse effects with higher dosing.
Important Clinical Considerations
Why 5mg is the Standard
- Efficacy plateau: The dose-response curve flattens beyond 5mg, with minimal additional symptom improvement
- Safety profile: Lower doses minimize side effects (headache, dyspepsia, back pain, myalgia) while maintaining efficacy
- Cost-effectiveness: No justification for higher doses without additional benefit
- Regulatory approval: Only 5mg has undergone the rigorous evaluation needed for FDA approval in BPH
Common Pitfall to Avoid
Do not confuse the "as-needed" erectile dysfunction dosing (which can be 10-20mg) with daily BPH dosing. These are completely different treatment paradigms with different pharmacokinetic considerations.
Renal Impairment Exception
In patients with moderate renal impairment (CrCl 30-50 mL/min), start with 2.5mg daily and may increase to 5mg based on individual response 11. Even in this context, 10mg daily is not recommended.
Combination Therapy Warning
The AUA Guidelines specifically state that clinicians should NOT offer the combination of low-dose daily 5mg tadalafil with alpha blockers, as it offers no advantages in symptom improvement over either agent alone (Moderate Recommendation; Evidence Level: Grade C) 22.
Bottom line: Prescribe tadalafil 5mg once daily for BPH. There is no role for 10mg daily dosing in this indication.